(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 16.86% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 7.73%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.39%.
Evolent Health's revenue in 2026 is $2,097,018,000.On average, 17 Wall Street analysts forecast EVH's revenue for 2026 to be $285,813,998,880, with the lowest EVH revenue forecast at $269,533,454,640, and the highest EVH revenue forecast at $310,008,696,570. On average, 17 Wall Street analysts forecast EVH's revenue for 2027 to be $335,107,868,940, with the lowest EVH revenue forecast at $296,102,398,365, and the highest EVH revenue forecast at $372,643,568,160.
In 2028, EVH is forecast to generate $375,356,992,200 in revenue, with the lowest revenue forecast at $323,801,935,440 and the highest revenue forecast at $423,859,446,915.